CNBP was high expressed in MDR cells and after CNBP overexpression, the effects of sorafenib on cell apoptosis and proliferation in HCC cells were reversed, supporting that CNBP acts as a contributor in sorafenib resistance. The gene discussed is CNBP; the disease is hepatocellular carcinoma.